Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02655783
Other study ID # 12-143
Secondary ID
Status Completed
Phase N/A
First received March 4, 2015
Last updated October 27, 2016
Start date January 2013
Est. completion date September 2016

Study information

Verified date October 2016
Source Université de Sherbrooke
Contact n/a
Is FDA regulated No
Health authority Canada: Ministère santé et services sociaux du Québec
Study type Interventional

Clinical Trial Summary

The objective of this study is to compare the effects of use of normal saline (250 cc / h), with or without dextrose supplement, on the evolution of labor in nulliparous.


Description:

There is some controversy regarding intravenous hydration of patients during labor. While the use of a fast flow of hydration appears to be recognized beneficial, the addition of glucose is less well accepted. However studies on exercise physiology clearly demonstrates improved performance of skeletal muscle by increased hydration and carbohydrate replacement during prolonged exercise. This situation is similar to the condition of the uterus in labor especially since it is now established that glucose represents its principal source of energy.

However, the effect of an additional carbohydrate intake on the evolution of labor has not been extensively studied until now, and there are several schools of thought on this subject. While some studies show that such glucose addition could reduce the total duration of labor as well as its second stage, others claim that this glucose supplement offers no benefit and may even be harmful to the fetus.

It therefore seems imperative to conduct a study to compare the use of hydration with normal saline with or without dextrose during labor, as recommended in current flow (250 cc / h). To our knowledge, this has never been done.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date September 2016
Est. primary completion date March 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- nulliparous woman

- monofetal pregnancy

- delivery at term

- elective induction

- favorable cervix (Bishop score of at least 6)

- cephalic presentation

Exclusion Criteria:

- diabetes

- preeclampsia

- maternal heart disease

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)


Related Conditions & MeSH terms


Intervention

Other:
5% dextrose
women with an elective induction of labor receive IV hydratation (250 ml/h) with a normal saline solution + 5% dextrose
normal saline
women with an elective induction of labor receive IV hydratation (250 ml/h) with a normal saline solution

Locations

Country Name City State
Canada Centre Hospitalier Universitaire de Sherbrooke Sherbrooke Quebec

Sponsors (1)

Lead Sponsor Collaborator
Université de Sherbrooke

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary 2nd stage of labor during delivery of a first baby, for an average of 5 hours No
See also
  Status Clinical Trial Phase
Completed NCT01765881 - Comparison Between 25 µg Vaginal Misoprostol vs Slow Release Pessary PGE2 Phase 2
Completed NCT02570620 - Contribution of Ultrasonography in the Evaluation of Cervical Induction-delivery Time N/A
Recruiting NCT01506102 - Thromboelastography During and After Delivery N/A
Recruiting NCT01505192 - Noninvasive Continuous Measurement of SpHb After Spontaneous Vaginal Delivery N/A